MSS is the brand behind the next-gen bioManufacturing & delivery Science Symposium, an international event focused on advances in biopharmaceutical technology. Its 2026 symposium takes place September 14–16 in Bled, Slovenia, in a hybrid format that welcomes both onsite and online participants. The program addresses production solutions across the development and manufacturing journey, covering upstream and downstream processing as well as advanced analytics. Its subject areas include gene therapies, vaccines, and complex biological products such as plasma, proteins, and enzymes.

MSS brings together researchers, industry professionals, and other participants to explore innovative production methods, delivery systems, and analytical approaches. The 2026 program features speakers from universities, biotechnology companies, and other organizations, with topics ranging from RNA vaccines and gene therapy vectors to plasma fractionation and purification technologies. Attendees can also access lectures, posters, and Young Researchers’ Corner presentations through the digital abstract book. Alongside scientific sessions, MSS emphasizes networking and professional connections.